Quick Answer
Kodiak Sciences Inc. reported Cash And Cash Equivalents At Carrying Value of $209.86 million for the year ending 2025.
- Kodiak Sciences Inc. showed an increase of +24.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Kodiak Sciences Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $6.39 million | Q1 2018: $22.81 million | Q2 2018: $17.64 million | Q3 2018: $11.59 million | Q1 2019: $57.22 million | Q2 2019: $44.97 million | Q3 2019: $37.03 million | Q1 2020: $226.46 million | Q2 2020: $269.84 million | Q3 2020: $291.59 million | Q1 2021: $920.46 million | Q2 2021: $880.87 million | Q3 2021: $799.25 million | Q1 2022: $671.73 million | Q2 2022: $172.69 million | Q3 2022: $178.41 million | Q1 2023: $316.62 million | Q2 2023: $378.67 million | Q3 2023: $345.67 million | Q1 2024: $245.92 million | Q2 2024: $219.23 million | Q3 2024: $197.86 million | Q1 2025: $138.85 million | Q2 2025: $104.17 million | Q3 2025: $72.04 million.
- Over the full 10 years of available data (2016 to 2025), Kodiak Sciences Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 2,081.1%.
- Historical annual values: Fiscal year 2025: $209.86 million | Fiscal year 2024: $168.07 million | Fiscal year 2023: $285.51 million | Fiscal year 2022: $190.43 million | Fiscal year 2021: $731.51 million | Fiscal year 2020: $944.40 million | Fiscal year 2019: $211.80 million | Fiscal year 2018: $88.25 million | Fiscal year 2017: $1.40 million | Fiscal year 2016: $9.62 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: